MYFAIR CREAM

MyFair Cream: A Triple-Combination Therapy for Hyperpigmentation

This WHO GMP-certified topical formulation targets hyperpigmentation (e.g., melasma, dark patches) through the synergistic action of three pharmacologically active compounds:

• Hydroquinone (2% w/w): A depigmenting agent that interferes with melanin synthesis.
• Mometasone (0.1% w/w): A potent topical corticosteroid that provides anti-inflammatory, anti-pruritic, and vasoconstrictive properties, mitigating associated redness and inflammation.
• Tretinoin (0.025% w/w): A retinoid that promotes epidermal turnover, facilitating the removal of pigmented keratinocytes.

Usage is indicated for individuals presenting with uneven skin tone, dark spots, or melasma who are seeking dermatological treatment for complexion equalization.